Stockreport

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

Genenta Science S.p.A.  (GNTA) 
PDF MILAN and NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased [Read more]